Alfonso Alarcon

Strategy & Marketing at Insight Surgical Technologies
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Boston, Massachusetts, United States, US
Languages
  • Spanish Native or bilingual proficiency
  • English Native or bilingual proficiency
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Licensing Academy in Intellectual Property & Technology Transfer
    University of California, Davis - School of Law
  • Venture Capital University Online
    VC University

Experience

  • Insight Surgical Technologies
    • United States
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Strategy & Marketing
      • Jun 2023 - Present

      IST is a clinical-stage, IGS company developing quantitative fluorescence imaging (qFI) and autonomously updated imaging technology that augment the neurosurgeon’s view of the evolving operative field to enhance surgical treatment. IST is a clinical-stage, IGS company developing quantitative fluorescence imaging (qFI) and autonomously updated imaging technology that augment the neurosurgeon’s view of the evolving operative field to enhance surgical treatment.

  • REVA Medical, LLC.
    • United States
    • Medical Device
    • 1 - 100 Employee
    • Consultant
      • Jun 2023 - Present

      REVA is a leader in bioresorbable polymer technologies for vascular applications. REVA is a leader in bioresorbable polymer technologies for vascular applications.

  • Magnuson Center for Entrepreneurship at Dartmouth
    • United States
    • Higher Education
    • 1 - 100 Employee
    • Venture Development | Dartmouth Innovations Accelerator for Cancer
      • Sep 2022 - Apr 2023

      The Accelerator is a joint initiative of the Dartmouth Cancer Center, the Geisel School of Medicine, and the Magnuson to advance new technologies and treatments for cancer (therapeutics, devices, diagnostics & life science tools). The Accelerator is a joint initiative of the Dartmouth Cancer Center, the Geisel School of Medicine, and the Magnuson to advance new technologies and treatments for cancer (therapeutics, devices, diagnostics & life science tools).

  • General Inception
    • United States
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Summer Associate | MedTech & Digital Health
      • May 2022 - Aug 2022

      GI is an institutional co-founder for science-based companies bringing specialized expertise, operational resources, and capital to innovation at Inception. GI is backed by Northpond Ventures, OMX Ventures, Paladin Capital, and Genoa Ventures. GI is an institutional co-founder for science-based companies bringing specialized expertise, operational resources, and capital to innovation at Inception. GI is backed by Northpond Ventures, OMX Ventures, Paladin Capital, and Genoa Ventures.

  • SHEPHERD Therapeutics
    • United States
    • Staffing and Recruiting
    • Business Development | DELVE Platform
      • Jun 2021 - May 2022

      SHEPHERD is a precision oncology company leveraging whole transcriptome RNA sequencing and computational methods to unlock the potential for new and existing molecules to benefit patients from bench to bedside.

    • Business Analyst | Therapeutics
      • Jun 2019 - May 2021

      Key projects included conducting commercial due diligence for in-licensing deals, pipeline prioritization, indication selection & business case development, partnerships and fundraising planning Subject of Harvard Business School Case 619-012, November 2018. Raman, Ananth, John Masko, and Aldo Sesia. "David Hysong and SHEPHERD Therapeutics."

  • X-COR Therapeutics
    • United States
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Project Analyst
      • Jan 2019 - May 2019

      Medical device company developing an extracorporeal CO2 removal device that uses ultra-low-blood flows for a cheaper, safer & more accessible treatment for acute respiratory failure. Medical device company developing an extracorporeal CO2 removal device that uses ultra-low-blood flows for a cheaper, safer & more accessible treatment for acute respiratory failure.

  • Massachusetts Life Sciences Center
    • United States
    • Government Administration
    • 1 - 100 Employee
    • Business Development Analyst
      • Aug 2018 - Dec 2018

      State economic development and investment agency. The MLSC has deployed $700M+ through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. State economic development and investment agency. The MLSC has deployed $700M+ through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs.

  • Brimatech Services GmbH
    • Austria
    • Market Research
    • 1 - 100 Employee
    • Market Research Intern
      • Jun 2017 - Sep 2017

      Consulting firm focused on high-tech industries. Brimatech supports the European Space Agency's Technology Transfer Program. Consulting firm focused on high-tech industries. Brimatech supports the European Space Agency's Technology Transfer Program.

Education

  • Dartmouth College
    MEM, Master of Engineering Management
    2022 - 2023
  • Texas Tech University
    BS, Industrial Engineering
    2013 - 2018
  • Stanford University
    Summer Session

Community

You need to have a working account to view this content. Click here to join now